Novogen LTD
SEC CIK 1075880 · NVGN · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Davidson Ebru | Director | filed 2026 - 2026 |
| Apple Robert F | Director | filed 2026 - 2026 |
| Coffey Steven R. S. | Director | filed 2026 - 2026 |
| Austin Josiah T | Director | filed 2006 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Levine James E. | Chief Financial Officer | filed 2026 - 2026 |
| Rao Sudha | Chief Scientific Officer | filed 2026 - 2026 |
| Friend John E. II | Chief Executive Officer | filed 2026 - 2026 |
| Cain David | Director, CMC | filed 2026 - 2026 |
| Bonacorda Jeffrey | VP, Finance and Controller | filed 2026 - 2026 |
| Simpson Jeremy | Program Director | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.